UnitedHealth stock slips as WSJ flags Optum mail-order refills ahead of 2026 guidance
UnitedHealth shares slipped 0.2% to $331.19 after a Wall Street Journal report said insurer-owned mail-order pharmacies, including UnitedHealth’s, dispensed billions in excess prescription drugs to Medicare patients. The Journal found mail-order pharmacies made up 9% of Medicare prescriptions but 37% of excess drugs from 2021 to 2023. Investors await UnitedHealth’s Jan. 27 results and 2026 guidance.